Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 26Unknown 12Recruiting 9Not yet recruiting 2Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 180INDUSTRY 29OTHER_GOV 4NIH 2NETWORK 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Lung Neoplasms 2Urinary Bladder Neoplasms 1Patient Compliance 1Neoplasms 1Neoplasm Metastasis 1Lung Diseases, Obstructive 1Kidney Diseases 1Keratosis, Actinic 1Glioma 1Glioblastoma 1Dementia 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

enzalutamide 1apalutamide 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × FED × Prostatic Neoplasms × Clear all
NCT06549036 2026-04-02

Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening

VA Office of Research and Development

Phase NA Not yet recruiting
228 enrolled
Genitourinary

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

James J. Peters Veterans Affairs Medical Center

Phase 2 Not yet recruiting
200 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡